News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
2,336 Results
Type
Article (104)
Press Release (2232)
Section
Business (1132)
Career Advice (71)
Deals (148)
Drug Development (145)
FDA (26)
Job Trends (49)
News (1431)
Policy (45)
Tag
Academia (2)
Alliances (92)
Alzheimer's disease (2)
Approvals (29)
Bankruptcy (2)
Best Places to Work (28)
Breast cancer (6)
Cancer (24)
Cardiovascular disease (1)
Career advice (70)
Cell therapy (2)
Clinical research (135)
Collaboration (1)
Compensation (2)
COVID-19 (3)
C-suite (1)
Data (21)
Diabetes (1)
Diagnostics (22)
Earnings (1091)
Events (133)
FDA (41)
Gene therapy (1)
Government (4)
Guidances (7)
Healthcare (53)
Infectious disease (3)
Inflammatory bowel disease (1)
Interviews (6)
IPO (112)
Job creations (25)
Job search strategy (65)
Legal (13)
Liver cancer (1)
Lymphoma (6)
Manufacturing (1)
MASH (1)
Medical device (50)
Medtech (50)
Mergers & acquisitions (34)
Metabolic disorders (2)
Neuropsychiatric disorders (1)
Neuroscience (4)
NextGen: Class of 2026 (6)
Non-profit (2)
Parkinson's disease (1)
Patents (1)
Patient recruitment (2)
People (73)
Phase 1 (38)
Phase 2 (51)
Phase 3 (57)
Pipeline (68)
Postmarket research (7)
Preclinical (20)
Prostate cancer (1)
Real estate (16)
Regulatory (40)
Reports (1)
Research institute (2)
Resumes & cover letters (3)
Startups (6)
Women's health (2)
Date
Last 7 days (6)
Last 30 days (29)
Last 365 days (141)
2026 (34)
2025 (125)
2024 (130)
2023 (156)
2022 (181)
2021 (343)
2020 (148)
2019 (112)
2018 (70)
2017 (46)
2016 (19)
2015 (33)
2014 (25)
2013 (18)
2012 (21)
2011 (16)
2010 (30)
Location
Africa (2)
Alabama (1)
Arizona (3)
Asia (139)
Australia (11)
California (49)
Canada (8)
China (2)
Colorado (2)
Connecticut (2)
Delaware (4)
Europe (281)
Florida (8)
Georgia (2)
Idaho (1)
Illinois (5)
Indiana (1)
Japan (3)
Kansas (2)
Louisiana (1)
Maine (2)
Maryland (9)
Massachusetts (26)
Michigan (2)
Minnesota (7)
Nebraska (1)
New Hampshire (3)
New Jersey (17)
New York (12)
North Carolina (6)
Northern California (35)
Ohio (1)
Pennsylvania (14)
South America (6)
Southern California (10)
Texas (6)
United States (186)
Utah (1)
2,336 Results for "1141".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fast Melt Tablets Market Size Reach USD 11.41 Billion by 2032, Growing at a CAGR of 9.1% from 2024 to 2032
June 10, 2025
·
1 min read
Cell and Gene Therapy Supply Chain/Logistics Market Expected to Grow at a CAGR of 11.41% from 2024 to 2031
In recent years, the field of medicine has seen some ground-breaking developments with the emergence of Cell and Gene Therapies (CGT). CGT is rapidly altering the therapy arena, promising long-term patient maintenance or cure.
April 24, 2024
·
7 min read
Press Releases
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
February 24, 2026
·
16 min read
Press Releases
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
February 24, 2026
·
11 min read
Press Releases
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
March 5, 2026
·
14 min read
Deals
Centene Corporation Announces 2021 Guidance
Centene Corporation announced its 2021 financial guidance. Total revenues are expected to be $114.1 billion to $116.1 billion, and diluted earnings per share are expected to be $3.82 to $4.06.
December 18, 2020
·
12 min read
Press Releases
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update
February 12, 2026
·
16 min read
Press Releases
Tempus Reports Fourth Quarter and Full Year 2025 Results
February 25, 2026
·
19 min read
Press Releases
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
December 8, 2025
·
10 min read
Press Releases
MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results
August 15, 2025
·
4 min read
1 of 234
Next
